Albumins represent a group of acidic proteins, whose basic function is to regulate the colloidal osmotic pressure in the blood. It is found in bodily fluids as well as tissues of mammals and in plants too. Serum and plasma derived albumins are carbohydrate free and constitute about 55% to 62% of the total protein content. Albumin is produced in the liver, and gets secreted or diffused into the blood system. They play an important role in regulating blood volume and act as transporters for molecules such as hormones, bile salts, ions, etc. There are three types of albumin used; they are human serum albumin, bovine serum albumin, and recombinant albumin, and their application varies depending on their features. Plasma is the majorly used by-product that includes immunoglobulin, fibrinogen, thrombin, and serum albumin. Bovine serum albumin is isolated from cows and is often used as a standard in protein calibration, as blocking agent primarily in ELISA (Enzyme-linked Immunosorbent Assay) and western blot, and to solubilize lipids.
Animal whole blood contains the plasma and cellular fraction that can be used commercially for several applications such as in the food industry and cell culture media. Bovine serum albumin (BSA) is used in cell culture protocols as standard for protein concentrations (Bradford protein assay) as well as small molecule carriers. Globulin free bovine serum albumins are utilized in electrophoresis. Bovine serum albumin is primarily used as the basic component in many biological reagents for diagnostic purposes. Bovine serum albumins are used in vaccine production and have profound value in cell culture related work, including effective washing of cells and in cryopreservation. It is used as a nutrient in microbial or cell culture and as signal amplifier in biochemical assays. Bovine serum albumin is readily water soluble and its solution has a good shelf life if stored in frozen form. It is used as a stabilizer for several solubilized proteins and enzymes. Generally, bovine serum albumin precipitates at high concentration of neutral salts (ammonium sulfate), but readily coagulates by heat too. Hydrophobic aggregates are formed rapidly when albumin is heated at 50 ? or higher and does not revert back to its monomeric form even after cooling.
The global bovine serum albumin market holds immense potential and is anticipated to grow rapidly. Continuous research and development by companies to increase market share through launch of new versions of existing products with different grades of bovine serum albumin derivatives such as enzyme grade and food grade, has boosted the growth of the market. The bovine serum albumin market is driven by rising use of blood plasma products in the food industry; advances in bovine blood collection and processing; and increased demand for animal meat and animal protein among the human population. Other drivers of the bovine serum albumin market include widening scope of animal by-products in cell culture technology, increased demand for bovine serum albumin as an excipient in the pharmaceutical industry, and improvement in the supply chain and distribution network in the global bovine serum albumin market. Major restraints of the market are rise in bovine diseases resulting in reduced production, and increase in preference for alternative products.
The global bovine serum albumin market can be classified based on application, end-user, and region. Based on application, the bovine serum albumin market is segmented into in-vitro diagnostics, vaccine production, biochemical assays and others. Based on end users, the market can be segmented into pharmaceutical industry, diagnostic industry, research institutes and others. Based on region, the market is classified into Asia Pacific (APAC), Europe, Middle East & Africa (MEA), North America (NA), and Latin America (LA). Australia and New Zealand are high production regions of bovine serum albumin.
Major players in the bovine serum albumin market are Proliant Inc., Thermo Fisher Scientific Inc., LAMPIRE Biological Laboratories, Inc., Rocky Mountain Biologicals Inc., Sigma-Aldrich Co. (Merck KGaA), Kraeber & Co GmbH, and others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.